Brainsway (BWAY) Total Non-Current Liabilities (2018 - 2025)
Brainsway (BWAY) posted quarterly Total Non-Current Liabilities of $17.5 million for Q4 2025, up 5.26% year-on-year from $16.7 million in Q4 2024, and up 463.08% on a QoQ basis from -$4.8 million in Q3 2025.
Brainsway (BWAY) Total Non-Current Liabilities (2018 - 2025) Analysis & Trends
Brainsway (BWAY) has reported Total Non-Current Liabilities for 8 consecutive years, with $17.5 million the latest figure, recorded in Q4 2025.
- Quarterly Total Non-Current Liabilities rose 5.26% year-over-year to $17.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17.5 million (up 5.26% YoY) and the FY2025 annual result came in at $17.5 million, up 5.26% from the prior year.
- Total Non-Current Liabilities improved to $17.5 million in Q4 2025 per BWAY's latest filing, from -$4.8 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for BWAY reached as high as $17.9 million in Q2 2025 and fell as low as -$4.8 million in Q3 2025.
- A 5-year average of $9.6 million and a median of $11.3 million in 2022 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 43.22% — and 2025, when it gained 5.26%.
- Year by year, Total Non-Current Liabilities stood at $9.3 million in 2021, then climbed by 17.12% to $10.9 million in 2022, then climbed by 6.32% to $11.6 million in 2023, then soared by 43.22% to $16.7 million in 2024, then rose by 5.26% to $17.5 million in 2025.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $17.5 million, -$4.8 million, and $17.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.53 Mn |
| Sep 30, 2025 | -4.83 Mn |
| Jun 30, 2025 | 17.92 Mn |
| Mar 31, 2025 | -2.13 Mn |
| Dec 31, 2024 | 16.66 Mn |
| Dec 31, 2023 | 11.63 Mn |
| Dec 31, 2022 | 10.94 Mn |
| Dec 31, 2021 | 9.34 Mn |
| Dec 31, 2020 | 7.58 Mn |
| Sep 30, 2020 | 7.50 Mn |
| Dec 31, 2019 | 7.80 Mn |
| Sep 30, 2019 | 7.80 Mn |
| Dec 31, 2018 | 8.31 Mn |